This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
25 Oct 2010

Lonza and BD Diagnostis to collaborate

Lonza Group of Switzerland has signed an exclusive agreement with US-based BD Diagnostics for Lonza to commercialise its microCompass molecular assays on BD’s MAX system.

Lonza Group of Switzerland has signed an exclusive agreement with US-based BD Diagnostics, a division of Becton, Dickinson and Company, for Lonza to commercialise its microCompass molecular assays on BD’s MAX system.

Lonza has the exclusive worldwide licence to co-market the BD MAX system with the full microCompass product line in selected fields. The companies say microCompass assays on the BD Max system will provide an automated platform with same-day results for quality control testing in the pharmaceutical and personal care market segments.

Lonza and BD are also developing easy to use automated rapid microbial testing systems.

‘Working with Lonza will accelerate the availability of an integrated molecular quality and process control system for industrial microbiologists,’ said Tom Polen, president of BD Diagnostics – Diagnostic Systems.

Doug Danne, head of the Rapid Testing Solutions business unit of Lonza, added: ‘Together through this partnersh

Related News